Search results for: 'needs aggregator'

Hot melt adhesives (HMAs) are a major component in packaging, nonwovens, furniture, automotive, construction, bookbinding, and other applications. HMAs have multiple advantages over other adhesive formulations, such as faster drying and setting, cost-effectiveness, and low volatile organic compound (VOC) emissions. Because HMAs have longer shelf li...

24 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

Infographics

×

Key Issues Addressed

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

30 Jun 2023  |  Global  |  Technology Research

Neonatal Monitoring: Technology Innovation and Growth Opportunities

AI-enabled Noninvasive Monitoring that Offers Real-time Feedback and Intelligent Decision-making Drives Transformational Growth.

Infographics

×

Neonatal monitoring medical technologies monitor newborn babies’ health and vital signs in the first few days or weeks of their life. These technologies are used in neonatal intensive care units (NICUs) and other hospital settings or at home. Some commonly used neonatal monitoring devices include electrocardiography (ECG) monitors, pulse oximetry m...

CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...

14 Dec 2022  |  Europe  |  Market Research

Analysis of the European UCaaS Market—Forecast to 2028

A Return to Growth as Businesses Adapt to and Shape the New Normal

Infographics

×

This study provides an in-depth analysis of the European hosted IP telephony and UCaaS market, including a forecast of installed users, average prices and provider revenue until 2028. The study discusses the impact of the COVID-19 epidemic on businesses and users, and the effects of economic hardship on services adoption and provider growth strateg...

This Frost & Sullivan study analyzes the competitiveness and dynamics of the various types of feedstocks available for the petrochemical industry, with the intention of revealing how the growing concerns and the subsequent efforts to reduce the use of fossil fuels in transportation and energy industries will impact the availability of fossil-based ...

31 Dec 2019  |  North America  |  Market Research

Global Biometrics Market, Forecast to 2024

eGovernance, Mobile Biometrics and eCommerce Drive the Ubiquity of Biometrics in Commercial and Government Applications

Infographics

×

The global biometrics market is at a high growth stage due to the ubiquity of dominant biometric modalities such as fingerprint and facial recognition. The deployment of biometrics is increasingly pervasive in both governmental and commercial sectors because of ease of use and the high degree of convenience offered by the technology. Key applicatio...

The global optical time domain reflectometer (OTDR) market registered revenues of about $200 million in 2019, growing at an average rate of 9% year-on-year. The objective of this Radar is to identify the key companies, their success factors, and opportunities for growth. The study compares different companies on a Growth Index and Innovation Index....

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...